A Unique High-Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome

Gautam K Singh1,2, Conor McClenaghan2,3, Manish Aggarwal1

  • 1Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO.

Insights

Cantu syndrome (CS) causes high-output cardiac hypertrophy with enhanced ventricular function due to low systemic vascular resistance. This condition can progress to high-output heart failure, particularly in older individuals.

Area of Science:

  • Cardiology
  • Genetics
  • Physiology

Background:

  • Left ventricular hypertrophy (LVH) typically presents with reduced systolic/diastolic function, a risk factor for congestive heart failure.
  • A less recognized phenotype of LVH involves enhanced ventricular function and increased cardiac output, potentially leading to high-output heart failure.
  • This presentation can cause diagnostic and management challenges.

Purpose of the Study:

  • To systematically characterize the cardiovascular phenotype of high-output cardiac hypertrophy in individuals with Cantu syndrome (CS).
  • To investigate the long-term consequences of enhanced ventricular function and low systemic vascular resistance in CS patients.

Main Methods:

  • Longitudinal study of 31 subjects with CS and confirmed ABCC9 variants.
  • Assessment of cardiovascular phenotype, including left ventricular mass index and blood pressure, compared to controls.
  • Evaluation of cardiac function and systemic vascular resistance.

Main Results:

  • CS subjects exhibited significant left ventricular hypertrophy (LVMI 86.7 g/m² vs. 26.6 g/m² in controls) and low blood pressure (systolic 94.5 mmHg, diastolic 60 mmHg).
  • Most CS subjects (21/31) showed eccentric hypertrophy with normal left ventricular wall thickness.
  • Congestive heart failure symptoms were observed in 4 of 5 CS subjects over 40 years old.

Conclusions:

  • The study defines the natural history of high-output cardiac hypertrophy in CS, driven by reduced systemic vascular resistance.
  • Cantu syndrome serves as a key model for understanding the long-term effects of high-output hypertrophy.
  • Progression to high-output heart failure is a potential outcome in individuals with CS.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
23
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25